Pricing Log in Create free account

PMGC Holdings Inc. (ELAB) vs Valion Bio, Inc. (VBIO)

PMGC Holdings Inc. and Valion Bio, Inc. are both Biotechnology companies. PMGC Holdings Inc. and Valion Bio, Inc. are of similar size ($2.5M and $2.4M). PMGC Holdings Inc. grew revenue faster over the last twelve months: 5.41% against −49.6%. Valion Bio, Inc. has the higher net margin (0.00% vs −523.0%) and the lower return on invested capital (−61.0% vs 0.00%). Across the 17 metrics below, PMGC Holdings Inc. leads on 10 and Valion Bio, Inc. on 7.

Valuation

Metric ELAB VBIO Biotechnology median
P/E n/m n/m 8.50
P/S 0.52 0.33 9.71
P/B 0.08 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.53 n/m 0.64
EV/Sales (6.66) 11.28 9.21
Earnings yield (38,441.73%) (15,509.47%) (33.15%)
Free cash flow yield (665.71%) (9,619.81%) (25.50%)

Profitability

Metric ELAB VBIO Biotechnology median
Gross margin 31.08% (58.09%) 65.16%
Operating margin (458.63%) 0.00% 0.00%
Net margin (522.99%) 0.00% 0.00%
Free cash flow margin (348.69%) 0.00% 0.00%
Return on equity (104.60%) (489.30%) (56.36%)
Return on assets (58.71%) (104.96%) (48.04%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric ELAB VBIO Biotechnology median
Revenue growth (TTM) 5.41% (49.63%) 6.02%
EPS growth (last fiscal year) 94.22% 60.16% 30.26%
Revenue growth, 5-year CAGR — 13.18% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ELAB VBIO Biotechnology median
Debt to equity 0.02 0.62 0.00
Current ratio 1.36 1.11 4.72
Net debt to EBITDA 0.87 0.79 0.96

Dividend

Metric ELAB VBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELAB VBIO Biotechnology median
Market cap 2.46m 2.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack